Improved outcome in pediatric AML due to augmented supportive care | Zendy

Jastaniah Wasil | Zendy; Abrar Mohammed Burhan | Zendy; Khattab Taha M. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Improved outcome in pediatric AML due to augmented supportive care

Author(s) -

Jastaniah Wasil,

Abrar Mohammed Burhan,

Khattab Taha M.

Publication year - 2012

Publication title -

pediatric blood and cancer

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.116

H-Index - 105

eISSN - 1545-5017

pISSN - 1545-5009

DOI - 10.1002/pbc.24195

Subject(s) - medicine , blood cancer , myeloid leukemia , supportive psychotherapy , childhood cancer , pediatrics , retrospective cohort study , protocol (science) , cancer , intensive care medicine , alternative medicine , pathology

We conducted a retrospective review of patients treated following the MRC acute myeloid leukemia (AML) 10 protocol to determine if supportive care measures sequentially introduced by our institution led to a significant improvement in treatment‐related mortality (TRM) in newly diagnosed pediatric patients with AML. Patients were partitioned based on supportive care measures into era1, from 1996 to 2002 (n = 20), and era2, from 2003 to 2011 (n = 40). The introduced supportive care measures reduced the TRM from 23.4% in era1 to 2.5% in era2 ( P = 0.034). The results demonstrate that supportive care is a significant factor in determining the outcome of childhood AML. Pediatr Blood Cancer 2012; 59: 919–921. © 2012 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research